Ultrasound-enhanced systemic thrombolysis

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 22:06, 8 November 2020 (Add: s2cid, pmid. | You can use this bot yourself. Report bugs here. | Suggested by Abductive | All pages linked from cached copy of User:Abductive/sandbox | via #UCB_webform_linked 266/281). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Ultrasound-enhanced systemic thrombolysis
Specialtycardiovascular

Ultrasound-enhanced systemic thrombolysis (UEST) is a medical technology that uses ultrasound to enhance the effects of thrombolytic drugs. To treat the blood clots causing strokes, transcranial Doppler ultrasonography is used. It is thought that transcranial doppler ultrasonography aimed at residual obstructive intracranial blood flow may help expose thrombi to tissue plasminogen activator or other thrombolytic drugs.

Studies have shown that complete recanalisation or dramatic clinical recovery can be increased by more than 19% when using transcranial doppler ultrasonography.

UEST is also sometimes used in the thrombolytic treatment of myocardial infarctions.[1]

See also

References

  1. ^ Xuedong Shen; Nair, C.; Holmberg, M.; Mooss, A.; Arouni, A.; Esterbrooks, D. (18 November 2009). "Therapeutic Ultrasound-Enhanced Thrombolysis in Patients With Acute Myocardial Infarction". Angiology. 61 (3): 253–258. doi:10.1177/0003319709343287. PMID 19926625. S2CID 33063149.

External links


Stub icon

This medical treatment–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Ultrasound-enhanced_systemic_thrombolysis&oldid=987730607"